Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients

Neuroscience Letters

Volumn 250, Issue 1, 1998, Pages 69-71

  Hiltunen, Mikko ^a   Mannermaa, Arto ^a   Helisalmi, Seppo ^a   Koivisto, Anne ^a   Lehtovirta, Maarit ^a   Ryynänen, Markku ^a   Riekkinen Sr , Paavo ^a,b   Soininen, Hilkka ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's disease; Apolipoprotein E4 allele; Butyrylcholinesterase K variant; Chromosome 3; Genetics; Linkage disequilibrium

Indexed keywords

APOLIPOPROTEIN E4; CHOLINESTERASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 3; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FINLAND; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BUTYRYLCHOLINESTERASE; FEMALE; FINLAND; HUMANS; LINKAGE DISEQUILIBRIUM; MALE;

EID: 0032568899     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00453-4     Document Type: Article

References (19)

1. Atack J.R., Perry E.K., Bonham J.R., Perry R.H. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J. Neurochem. 47:1986;263-277.
2. Bartels C.F., Jensen F.S., Lockridge O., van der Spek A.F.L., Rubinstein H.M., Lubrano T., La Du B.N. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am. J. Hum. Genet. 50:1992;1086-1103.
3. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type ε4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
4. Gómez-Ramos P., Bouras C., Morán M.A. Ultrastructual localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients. Brain Res. 640:1994;17-24.
5. Guillozet A.L., Smiley J.F., Mash D.C., Mesulam M.-M. Butyrylcholinesterase in the life cycle of amyloid plaques. Ann. Neurol. 42:1997;909-918.
6. Jensen F.S., Nielsen L.R., Schwartz M. Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. Hum. Hered. 46:1996;26-31.
7. Jorde L.B. Linkage disequilibrium as a gene-mapping tool. Am. J. Hum. Genet. 56:1995;11-14.
8. Kamboh M.I., Sanghera D.K., Ferrell R.E., DeKosky S.T. APOE4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat. Genet. 10:1995;486-488.
9. Layer P., Weikert T., Albert R. Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of non-enzymatic mechanism. Cell Tissue Res. 273:1993;219-226.
10. Lehmann D.J., Johnston C., Smith A.D. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum. Mol. Genet. 11:1997;1933-1936.
11. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
12. Mesulam M.M., Geula C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann. Neurol. 36:1994;722-727.
13. Perry E.K., Perry R.H., Blessed G., Tomlinson B.E. Changes in brain cholinesterases in senile dementia of the Alzheimer type. Neuropathol. Appl. Neurobiol. 4:1978;273-277.
14. Poirier J. Apolipoprotein E in animal models of CNS injury and Alzheimer's disease. Trends. Neurosci. 17:1994;525-530.
15. Soininen H., Lehtovirta M., Helisalmi S., Linnaranta K., Heinonen O., Riekkinen P. Sr. Increased acetylcholinesterase activity in the CSF of Alzheimer patients carrying apolipoprotein ε4 allele. NeuroReport. 6:1995;2518-2520.
16. Soininen H., Kosunen O., Helisalmi S., Mannermaa A., Paljärvi L., Talasniemi S., Ryynänen M., Riekkinen P. Sr. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein ε4 allele. Neurosci. Lett. 187:1995;79-82.
17. Tsukamoto K., Watanabe T., Matsushima T., Kinoshita M., Kato H., Hashimoto Y., Kurokawa K., Teramoto T. Determination by PCR-RFLP of apoE genotype in a Japanese population. J. Lab. Clin. Med. 121:1993;598-602.
18. Vandenplas S., Grobler-Rabie A., Brebner K., Ricketts M., Wallis G., Bester A., Boyd C., Mathew C. Blot hybridization of genomic DNA. J. Med. Genet. 21:1984;164-172.
19. Wragg, M., Hutton, M., Talbot, C. and the Alzheimer's Disease Collaborative Group, Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease, Lancet, 347 (1996) 509-512.